BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Hypothalamus
,
Human chorionic gonadotropin
,
Trichostatin A
,
rs2476601
,
ERBB2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
catenin beta 1
Summary
General Info
Curated Studies
Most Correlated Studies
Progression of Irf8-/- CML-like disease into blast crisis after β-catenin activation
Cardiomyocytes overexpressing beta-catenin
Pancreatic cancer cells overexpressing beta-catenin or beta-catenin interacting protein 1 (ICAT)
Fetal kidneys in culture after beta-catenin activation
Hepatocellular carcinomas driven by constitutively active beta-catenin
Explore Curated Studies Results
Literature
Most Relevant Literature
β-catenin inhibitors in cancer therapeutics: intricacies and way forward.
Novel truncating variants in CTNNB1 cause familial exudative vitreoretinopathy.
Crosstalk Between β-CATENIN-Mediated Cell Adhesion and the WNT Signaling Pathway.
SETDB1 confers colorectal cancer metastasis by regulation of WNT/β-catenin signaling.
Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherpar…
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ